Results 131 to 140 of about 36,737 (275)

Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis

open access: gold, 2023
Kaini Shen   +7 more
openalex   +1 more source

Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms [PDF]

open access: bronze, 2022
Gabriela Neculae   +10 more
openalex   +1 more source

Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis

open access: yesPharmaceuticals
Background/Objectives: Antibody light chains form amyloid fibrils that lead to progressive tissue damage in amyloid light chain (AL) amyloidosis. The properties of each patient’s unique light chain appear to determine its propensity to form amyloid.
Gareth J. Morgan   +4 more
doaj   +1 more source

A novel echocardiographic risk score for light-chain amyloidosis [PDF]

open access: gold, 2023
Paul Geenty   +7 more
openalex   +1 more source

Insight from an autopsy in a patient with rapidly worsening heart failure due to amyloid light-chain cardiac amyloidosis: A case report [PDF]

open access: bronze, 2020
Hiroaki Yokoyama   +5 more
openalex   +1 more source

Near tetrapoloid karyotype with translocation t(11;14) in a Moroccan patient with amyloid light-chain amyloidosis and multiple myeloma

open access: gold, 2020
Hasna Hamdaoui   +6 more
openalex   +1 more source

A case of light chain (AL) amyloidosis with heart failure, renal dysfunction, and heparin-induced thrombocytopenia successfully treated with peritoneal dialysis

open access: green, 2020
Shingo Nakayama   +10 more
openalex   +2 more sources

Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis [PDF]

open access: bronze, 2017
Jean‐Baptiste Gibier   +11 more
openalex   +1 more source

Home - About - Disclaimer - Privacy